Nawal Dayoub
Nawal Dayoub has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Nayla Bushaqer
Obstetrics and Gynaecology, Royal College of Surgeons in Ireland - Bahrain, Busaiteen, BHR
5 shared publications - Abeer AlSada
Obstetrics and Gynaecology, Bahrain Defence Force Hospital, Royal Medical Services, Riffa, BHR
2 shared publications Asif Raja
2 shared publications- Bedoor Al Omran
Radiology Department, Bahrain Defence Force Hospital
2 shared publications - Haya Albuainain
Obstetrics and Gynaecology, Bahrain Defense Force (BDF) Hospital, Riffa, BHR
2 shared publications Haya Rawah
PSMMC, IVF Unit, Riyadh, Saudi Arabia
2 shared publications
Latest Publications
- Open Access
- 20 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29345
Maternal Obesity: An Obstetric Risk
Objective: To analyze the obstetric risks and to evaluate the effects of maternal obesity during pregnancy and postpartum period. Method: This is a retrospective study of pregnant women with a BMI of more the 30 conducted at Bahrain Defence Force Hospital, West Riffa, Bahrain, from September 2019 to August 2020. Data includes demographic characteristics, and course of pregnancy from gestational age 24 weeks, through intrapartum to the postpartum period. Adverse maternal effects and delivery complications were the primary study outcomes. The BMI was calculated at the time of the booking visit. Comparative analysis was done to calculate the odds of each outcome taking a non-obese group (BMI less than 30) as a reference. Results: The total number of pregnant women studied was 2972, out of which 1657 had BMI ≥30. In our study, women with high BMI were older (p<0.0001). High BMI was associated with high parity and higher miscarriage history. High BMI increased the risk of developing hypertension (OR 2.5; 95%CI 1.1-5.3). This analysis also found that high BMI was associated with increased risk of antepartum hemorrhage (OR 2.4; 95%CI 1-5.4), postpartum complications (OR1.6; 95%CI 1.1-2.2), and a hospital stay of more than five days (OR 1.6; 95%CI 1.3-2). High BMI patients were less likely to have Intrauterine growth restriction (OR 0.6; 95%CI 0.3-0.9). High BMI patients did not have an increased risk of gestational diabetes mellitus, induction of labor, or caesarean birth. Conclusion: Higher BMI pregnant women are associated with higher incidences of hypertension. The high BMI group also had a significant relationship with antepartum hemorrhage and postpartum length of stay.
- 20 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29345
Open AccessMaternal Obesity: An Obstetric Risk
Objective: To analyze the obstetric risks and to evaluate the effects of maternal obesity during pregnancy and postpartum period. Method: This is a retrospective study of pregnant women with a BMI of more the 30 conducted at Bahrain Defence Force Hospital, West Riffa, Bahrain, from September 2019 to August 2020. Data includes demographic characteristics, and course of pregnancy from gestational age 24 weeks, through intrapartum to the postpartum period. Adverse maternal effects and delivery complications were the primary study outcomes. The BMI was calculated at the time of the booking visit. Comparative analysis was done to calculate the odds of each outcome taking a non-obese group (BMI less than 30) as a reference. Results: The total number of pregnant women studied was 2972, out of which 1657 had BMI ≥30. In our study, women with high BMI were older (p<0.0001). High BMI was associated with high parity and higher miscarriage history. High BMI increased the risk of developing hypertension (OR 2.5; 95%CI 1.1-5.3). This analysis also found that high BMI was associated with increased risk of antepartum hemorrhage (OR 2.4; 95%CI 1-5.4), postpartum complications (OR1.6; 95%CI 1.1-2.2), and a hospital stay of more than five days (OR 1.6; 95%CI 1.3-2). High BMI patients were less likely to have Intrauterine growth restriction (OR 0.6; 95%CI 0.3-0.9). High BMI patients did not have an increased risk of gestational diabetes mellitus, induction of labor, or caesarean birth. Conclusion: Higher BMI pregnant women are associated with higher incidences of hypertension. The high BMI group also had a significant relationship with antepartum hemorrhage and postpartum length of stay.
- Open Access
- 1 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24637
Preeclampsia and Its Maternal and Perinatal Outcomes in Pregnant Women Managed in Bahrain’s Tertiary Care Hospital
Objective: Hypertensive disorders during pregnancy being the leading causes of maternal and fetal morbidity and mortality remains a serious health issue worldwide due to the high rate of adverse maternal outcomes and close association with neonatal morbidity and mortality. The purpose of our study was to ascertain the perinatal outcomes of preeclampsia (PE) in a tertiary care hospital in Bahrain. Methods: A retrospective cohort study was conducted from January 2018 to December 2019 in the department of Gynecology and Obstetrics in Bahrain Defense Hospital. The process of data collection included a baseline review of all women who had delivered during the study period in order to identify those with PE. Additionally, the postdelivery records of the mothers and newborns were reviewed to identify relevant maternal and neonatal outcomes. Results: During the research period, records revealed 142 patients with PE with a rate of 1.95%. The mean gestational age at diagnosis was 35.61 (± 3.69) weeks, ranging between 20 and 42 weeks. The mean birth weight was 2.64 ± 0.79 kg, ranging from 0.5-4.5 kg. Furthermore, most babies had an Apgar score of 9 at 5 minutes. The preterm delivery rate was (16.3%) and intrauterine growth restriction (IUGR) was seen in 19 patients (13.5%) and it was significantly higher in patients who presented between 30 and 34 gestational weeks P < 0.001. Twenty-one infants were admitted to the NICU primarily for prematurity and low birth weight. There was only one early neonatal death of a hydrops baby. One infant was stillborn with extreme prematurity at 24 weeks+4 days. Maternal complications included five abruption placentae (3.5%) cases, five HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) cases (3.5%), four eclampsia (2.8%) cases, and four patients had ICU admission. Other maternal complications included acute renal failure (ARF) in two patients (1.4%), pulmonary edema in one patient, and peripartum cardiomyopathy in one patient. Data showed that adverse pregnancy outcomes were significantly more common in those with PE as compared to other pregnant populations. Conclusion: Preeclampsia causes a remarkable increase in adverse maternal and perinatal outcomes as compared to the normotensive pregnant population. A regular goal-oriented clinical audit into perinatal morbidity and mortality associated with this condition and an active multidisciplinary approach to the management of pre-eclampsia patients in the hospital might improve the clinical outcomes.
- 1 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24637
Open AccessPreeclampsia and Its Maternal and Perinatal Outcomes in Pregnant Women Managed in Bahrain’s Tertiary Care Hospital
Objective: Hypertensive disorders during pregnancy being the leading causes of maternal and fetal morbidity and mortality remains a serious health issue worldwide due to the high rate of adverse maternal outcomes and close association with neonatal morbidity and mortality. The purpose of our study was to ascertain the perinatal outcomes of preeclampsia (PE) in a tertiary care hospital in Bahrain. Methods: A retrospective cohort study was conducted from January 2018 to December 2019 in the department of Gynecology and Obstetrics in Bahrain Defense Hospital. The process of data collection included a baseline review of all women who had delivered during the study period in order to identify those with PE. Additionally, the postdelivery records of the mothers and newborns were reviewed to identify relevant maternal and neonatal outcomes. Results: During the research period, records revealed 142 patients with PE with a rate of 1.95%. The mean gestational age at diagnosis was 35.61 (± 3.69) weeks, ranging between 20 and 42 weeks. The mean birth weight was 2.64 ± 0.79 kg, ranging from 0.5-4.5 kg. Furthermore, most babies had an Apgar score of 9 at 5 minutes. The preterm delivery rate was (16.3%) and intrauterine growth restriction (IUGR) was seen in 19 patients (13.5%) and it was significantly higher in patients who presented between 30 and 34 gestational weeks P < 0.001. Twenty-one infants were admitted to the NICU primarily for prematurity and low birth weight. There was only one early neonatal death of a hydrops baby. One infant was stillborn with extreme prematurity at 24 weeks+4 days. Maternal complications included five abruption placentae (3.5%) cases, five HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) cases (3.5%), four eclampsia (2.8%) cases, and four patients had ICU admission. Other maternal complications included acute renal failure (ARF) in two patients (1.4%), pulmonary edema in one patient, and peripartum cardiomyopathy in one patient. Data showed that adverse pregnancy outcomes were significantly more common in those with PE as compared to other pregnant populations. Conclusion: Preeclampsia causes a remarkable increase in adverse maternal and perinatal outcomes as compared to the normotensive pregnant population. A regular goal-oriented clinical audit into perinatal morbidity and mortality associated with this condition and an active multidisciplinary approach to the management of pre-eclampsia patients in the hospital might improve the clinical outcomes.
- Open Access
- 14 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22194
The Use of Beta-Human Chorionic Gonadotropin (β-hCG) Levels as a Predictor of Successful Medical Management of Ectopic Pregnancy
The early diagnosis of ectopic pregnancy is essential in determining the appropriate therapeutic approach. This study demonstrates the important factors considered in the prediction of a successful medical treatment, which will, in turn, improve the quality of patient counseling and guidance prior to the initiation of the treatment. This was a retrospective cohort study of 58 ectopic pregnancies that were treated medically with methotrexate in Bahrain Defense Force (BDF) Hospital from January 2016 to January 2021. All patients that were offered medical treatment of ectopic pregnancy and completed the follow-up were included in the study. StatsDirect software was used to analyze the baseline characteristics of the successful and failed medical treatment of ectopic groups. Simple linear regression was used to correlate initial beta-human chorionic gonadotropin (β-hCG) levels and the drop of β-hCG levels after one week of medical treatment. Patients were divided into two outcomes: the primary outcome represented in the successful treatment group, 68.9% (40/58), and the secondary outcome represented in the unsuccessful treatment group 31% (18/58). The mean β-hCG level in the successful group was significantly lower than that of the unsuccessful treatment group (1403.6±1421 IU/L versus 2845.1±1705 IU/L, p=0.001). There were no differences between the two groups with regards to the size of the adnexal mass, presence of gestational sac, or size of the gestational sac. The cut-off value of the initial β-hCG level for successful medical treatment was 2,141 IU/L, with 72% sensitivity, 75% specificity, and receiver operator curve (ROC) of 0.76 [95% confidence interval (CI) = 0.63 to 0.89)]. The cut-off value of β-hCG fell between day four and day seven and was 37.2%, with 78% sensitivity, 68% specificity, and a ROC curve of 0.72 (95% CI = 0.55 to 0.89). This study found that low initial β-hCG levels can be used to predict successful methotrexate treatment of ectopic pregnancy. In this cohort of patients, the cut-off level of initial β-hCG for successful treatment was 2141 IU/L.
- 14 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22194
Open AccessThe Use of Beta-Human Chorionic Gonadotropin (β-hCG) Levels as a Predictor of Successful Medical Management of Ectopic Pregnancy
The early diagnosis of ectopic pregnancy is essential in determining the appropriate therapeutic approach. This study demonstrates the important factors considered in the prediction of a successful medical treatment, which will, in turn, improve the quality of patient counseling and guidance prior to the initiation of the treatment. This was a retrospective cohort study of 58 ectopic pregnancies that were treated medically with methotrexate in Bahrain Defense Force (BDF) Hospital from January 2016 to January 2021. All patients that were offered medical treatment of ectopic pregnancy and completed the follow-up were included in the study. StatsDirect software was used to analyze the baseline characteristics of the successful and failed medical treatment of ectopic groups. Simple linear regression was used to correlate initial beta-human chorionic gonadotropin (β-hCG) levels and the drop of β-hCG levels after one week of medical treatment. Patients were divided into two outcomes: the primary outcome represented in the successful treatment group, 68.9% (40/58), and the secondary outcome represented in the unsuccessful treatment group 31% (18/58). The mean β-hCG level in the successful group was significantly lower than that of the unsuccessful treatment group (1403.6±1421 IU/L versus 2845.1±1705 IU/L, p=0.001). There were no differences between the two groups with regards to the size of the adnexal mass, presence of gestational sac, or size of the gestational sac. The cut-off value of the initial β-hCG level for successful medical treatment was 2,141 IU/L, with 72% sensitivity, 75% specificity, and receiver operator curve (ROC) of 0.76 [95% confidence interval (CI) = 0.63 to 0.89)]. The cut-off value of β-hCG fell between day four and day seven and was 37.2%, with 78% sensitivity, 68% specificity, and a ROC curve of 0.72 (95% CI = 0.55 to 0.89). This study found that low initial β-hCG levels can be used to predict successful methotrexate treatment of ectopic pregnancy. In this cohort of patients, the cut-off level of initial β-hCG for successful treatment was 2141 IU/L.
- Open Access
- 1 September 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (3) , 246-250
Antimullerian hormone (AMH) level and IVF/ICSI cycle outcome in expected poor responders
- 1 September 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (3) , 246-250
Open AccessAntimullerian hormone (AMH) level and IVF/ICSI cycle outcome in expected poor responders
- Open Access
- 30 June 2018
- Published by ClinMed International Library in Obstetrics and Gynaecology Cases - Reviews
- Vol. 5 (1)
Laparoscopic Management of Interstitial Ectopic Pregnancy with Endo GIA™ without Rupture
Interstitial pregnancy is uncommon, accounting for 2-4% of all ectopic pregnancies. It is potentially serious and mortality is most commonly due to rupture and subsequent hemorrhage. Both medical and surgical management options are available, depending on a given individual's case. Currently, the preferred surgical approach is laparoscopy. However, despite the presence of different laparoscopic techniques, there is no consensus on a single best technique.
- 30 June 2018
- Published by ClinMed International Library in Obstetrics and Gynaecology Cases - Reviews
- Vol. 5 (1)
Open AccessLaparoscopic Management of Interstitial Ectopic Pregnancy with Endo GIA™ without Rupture
Interstitial pregnancy is uncommon, accounting for 2-4% of all ectopic pregnancies. It is potentially serious and mortality is most commonly due to rupture and subsequent hemorrhage. Both medical and surgical management options are available, depending on a given individual's case. Currently, the preferred surgical approach is laparoscopy. However, despite the presence of different laparoscopic techniques, there is no consensus on a single best technique.
- 1 June 2018
- Published by Kezana LLC FZ in Bahrain Medical Bulletin
- Vol. 40 (2) , 93-96
Thrombocytopenia among Pregnant Women
- 1 June 2018
- Published by Kezana LLC FZ in Bahrain Medical Bulletin
- Vol. 40 (2) , 93-96
Thrombocytopenia among Pregnant Women
- Open Access
- 1 June 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (2) , 158-160
Pulmonary embolism and intraperitoneal bleeding in a patient with severe ovarian hyper stimulation syndrome (OHSS): A management dilemma
- 1 June 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (2) , 158-160
Open AccessPulmonary embolism and intraperitoneal bleeding in a patient with severe ovarian hyper stimulation syndrome (OHSS): A management dilemma
- Open Access
- 1 June 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (2) , 137-142
Progesterone level significance in agonist versus antagonist protocols
- 1 June 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (2) , 137-142
Open AccessProgesterone level significance in agonist versus antagonist protocols
- Open Access
- 1 March 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (1) , 14-18
Progesterone level on the day of triggering and pregnancy outcome in long GnRH agonist protocol
- 1 March 2018
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 23 (1) , 14-18
Open AccessProgesterone level on the day of triggering and pregnancy outcome in long GnRH agonist protocol
- Open Access
- 1 March 2018
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 39 (3) , 290-295
Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention
Follicular aspiration vs. coasting for OHSS prevention
- 1 March 2018
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 39 (3) , 290-295
Open AccessFollicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention
Follicular aspiration vs. coasting for OHSS prevention